StockNews.AI
CSBR
StockNews.AI
161 days

Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million

1. CSBR reported a 42% revenue increase to $17.0 million in Q3. 2. The company signed its first major data licensing deal up to $8.0 million.

Earnings
-2.45%Current Return
VS
+0.51%S&P 500
$9.7903/11 04:00 PM EDTEvent Start
$9.5503/12 10:23 PM EDTLatest Updated
3m saved
Insight
Article

FAQ

Why Bullish?

The significant revenue growth and a new data deal indicate strong market positioning. Historical trends show that new partnerships in biotech often lead to stock price uplifts.

How important is it?

The article outlines pivotal financial growth and strategic moves that could attract investor interest, influencing CSBR’s stock value.

Why Short Term?

The immediate financial results and licensing agreement are likely to influence investor sentiment swiftly. Similar past announcements have led to quick upward stock movements.

Related Companies

VRTXREGNKITE
HACKENSACK, NJ / ACCESS Newswire / March 11, 2025 / Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today announced its financial results for its third quarter of fiscal 2025, ended January 31, 2025. Third Quarter and Recent Highlights: Total revenue increased 42% to $17.0 million Gross profit of $10.4 million; gross margin of 61% Net income of approximately $4.5 million Adjusted EBITDA of $5.2 million Signed first data licensing deal worth up to $8.0 million Hired Matt Newman, Executive Vice President and General Manager, to lead and expand the development of Champions' data licensing platform Year to Date Highlights: Total revenue increased 23% to $44.6 million Gross profit of $23.5 million; gross margin of 53% Net income of $6.5 million Adjusted EBITDA of $8.3 million Ronnie Morris, CEO of Champions, commented, "Our third quarter was transformational, marked by our first major data licensing agreement-an important milestone toward monetizing our proprietary data platform.

Related News